QUCY - MAINZ BIOMED N.V.

0.5099
-0.007   -1.392%

Share volume: 306,679
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.16%

PREVIOUS CLOSE
CHG
CHG%
$0.52
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
8.37%
1 Month
2.29%
3 Months
-60.78%
6 Months
-67.93%
1 Year
-84.07%
2 Year
-43.26%
Key data
Stock price
$0.51
P/E Ratio 
0.00
DAY RANGE
$0.48 - $0.52
EPS 
N/A
52 WEEK RANGE
$0.40 - $4.43
52 WEEK CHANGE
-$85.56
MARKET CAP 
6.210 M
YIELD 
N/A
SHARES OUTSTANDING 
17.557 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
12-03-2024
NEXT EARNINGS DATE
04-29-2025
BETA 
0.26
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,605,996
AVERAGE 30 VOLUME 
$725,715
Company detail
CEO: Guido Baechler
Region: US
Website: mainzbiomed.com
Employees: 30
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Mainz Biomed B.V. develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany.

Recent news